Musculoskeletal Diseases Treatment market 2025 worldwide trends in new research report

Posted by kartik joshi on September 28th, 2022

Musculoskeletal diseases treatment market generated US$ 3,837.9 million in 2017 and is estimated to reach US$ 5,730.8 million by 2025, expanding at 5.3% CAGR from 2018 to 2025. The rising prevalence of musculoskeletal disorders, increasing elderly population, and technological advancement in musculoskeletal disease diagnosis are the crucial factors accredited for market expansion.

Musculoskeletal disorders are associated with sports, occupational injuries, and age-related dysfunctions. The most common ones are back-pain, rheumatoid arthritis, osteoporosis, gout, etc. According to the Arthritis Foundation statistics 2017, approximately 54 million adults worldwide were diagnosed with arthritis, while around 300,000 babies and children were found with rheumatic conditions. As per the Healthline Media’s report published in 2018, it is observed that rheumatoid arthritis affects 41 in every 100,000 people each year.

Sample Report Copy from Here

https://www.theinsightpartners.com/sample/TIPMD00002090/

The elderly population, particularly aged 65 and over, has been increasing. The geriatric population is estimated to grow at the rate of 3% every year. At present, Europe has the highest elderly population in the world. The geriatric population across the world is projected to reach around 1.4 billion by 2030 and 2.1 billion by 2050, respectively. Aging increases the risks of musculoskeletal diseases due to severe complications in the body. The considerable loss of mobility and physical independence is particularly exhausting in the elderly population.

Musculoskeletal disorders are treated with flexible imaging modalities that provides exclusively high resolution. This technique is adopted by several medical device manufacturers to develop advanced products and features. The treatment methodologies of musculoskeletal diseases have been technically upgraded over the past few years. For an instance, in March 2017, Toshiba Medical launched Aplio i-series ultrasound platform for quick and reliable musculoskeletal diagnosis. Konica Minolta Healthcare Americas in 2018, launched portable ultrasound system, SONIMAGE MX1, for the treatment of orthopedic conditions. Thus, the aforementioned parameters altogether drives the concerned market.

On the contrary, the high cost of diagnostic systems and lack of skilled professionals are the hindering factors of the global musculoskeletal diseases treatment market.

Based on diseases, the market is split into arthritis, osteoarthritis, osteoporosis, spondylitis, and others. An arthritis segment occupied 43.2% market share in 2017. It garnered US$ 1,657.6 million in 2017 and is expected to generate US$ 2,515.8 million by 2025 to grow at a CAGR of 5.5% during 2018–2025.

As per imaging modality, the global musculoskeletal diseases treatment market is segmented into computed tomography, magnetic resonance imaging, ultrasound, and others. With 36.5% market share, the computed tomography segment dominated the business in 2017. It accrued US$ 1,399.5 million in 2017 and is slated to amass US$ 2,106.1 million by 2025 to rise at a 5.4% CAGR throughout the forecast period.

Regionally speaking, North America dominated the market in 2017, accounting US$ 1,297.2 million. Later, it is speculated to hit US$ 1,947.3 million by 2025, featuring a CAGR of 5.3% for the forecast period, while Asia Pacific registered the highest CAGR of 5.8%. The regional market was worth US$ 1,013.2 million in 2017 and is likely to reach US$ 1,571.4 million by 2025.

Contact Us

Phone: +1-646-491-9876

Email Id: sales@theinsightpartners.com